The CEO of a former Fortune 500 company, who is also the daughter of a U.S. senator, is under fire from for jacking up the rates of life-saving anti-allergy device known as the EpiPen.
Heather Bresch, whose father is U.S. Sen. Joe Manchin, D-W.Va., became president of Mylan Pharmaceutical in 2009 and CEO in 2012. She is no stranger to controversy: She moved Mylan’s headquarters to the Netherlands last year after a corporate “inversion” merger with Abbott Laboratories.
The move enabled the company to operate its headquarters in the U.S. but maintain corporate citizenship in Holland, benefiting from a lower tax rate.
READ MORE: https://theintercept.com/2016/08/24/epipen-uproar-highlights-companys-fa...